1] Shafaq, N., “An Overview of Oxidative Stress and Antioxidant Defensive System”,Scientific Reports, 1 (8), (2012).
[2] Lee, J. Y., Hwang, W. I. and Lim, S. T., “Antioxidant and anticancer activities of organic extracts from Platycodon grandiflorum A. De Candolle roots”, J. Ethnopharm,. 93 (2), 409 (2004).
[3] Wang, Z. M., Ho, J. X., Ruble, J. R., Rose, J., Rüker, F., Ellenburg, M., Murphy, R., Click, J., Soistman, E. and L. Wilkerson, “Structural studies of several clinically important oncology drugs in complex with human serum albumin”, Biochim. Biophys. Acta., 1830 (12), 5356 (2013).
[4] Poór, M., Li, Y., Matisz, G., Kiss, L., Kunsági-Máté, S. and Kőszegi, T., “Quantitation of species differences in albumin–ligand interactions for bovine, human and rat serum albumins using fluorescence spectroscopy: A test case with some Sudlow's site I ligands”, J. Lumin., 145, 767 (2014).
[5] Yanase, K., Arai, R. and Sato, T., “Intermolecular interactions and molecular dynamics in bovine serum albumin solutions studied by small angle X-ray scattering and dielectric relaxation spectroscopy”, J. Mol. Liq., 200, 59 (2014).
[6] Michnik, A., Michalik, K., Kluczewska, A. and Drzazga, Z., “Comparative DSC study of human and bovine serum albumin”, J. Therm. Anal. Calor., 84 (1), 113 (2006).
[7] Elzoghby, A. O., Samy, W. M. and Elgindy, N. A., “Albumin-based nanoparticles as potential controlled release drug delivery systems”, J. Contr. Rel., 157 (2), 168 (2012).
[8] Gong, G., Xu, Y., Zhou, Y., Meng, Z., Ren, G., Zhao, Y., Zhang, X., Wu, J. and Hu, Y., “Molecular switch for the assembly of lipophilic drug incorporated plasma protein nanoparticles and in vivo image”, Biomacromolecules, 13, 23 (2011).
[9] Jiang, L., Xu, Y., Liu, Q., Tang, Y., Ge, L., Zheng, C., Zhu, J. and Liu, J., “A nontoxic disulfide bond reducing method for lipophilic drug-loaded albumin nanoparticle preparation: Formation dynamics, influencing factors and formation mechanisms investigation”, Int. J. Pharm, 443, 80 (2013).
[10] Wang, W., Huang, Y., Zhao, S., Shao, T. and Cheng, Y., “Human serum albumin (HSA) nanoparticles stabilized with intermolecular disulfide bonds”, Chem. Commun., 49 (22), 2234 (2013).
[11] Dai, J. and Mumper, R. J., “Plant phenolics: extraction, analysis and their antioxidant and anticancer properties”, Molecules, 15 (10), 7313 (2010).
[12] Bhattacharya, R. and Mukherjee, P., “Biological properties of “naked” metal nanoparticles”, Adv. drug delivery. rev., 60 (11), 1289 (2008).
[13] Kalishwaralal, K., BarathManiKanth, S., Pandian, S. R. K., Deepak, V. and Gurunathan, S., “Silver nano—a trove for retinal therapies”, J. Contr. Rel., 145 (2), 76 (2010).
[14] Lara, H. H., Ayala-Nuñez, N. V., Ixtepan-Turrent, L. and Rodriguez-Padilla, C., “Mode of antiviral action of silver nanoparticles against HIV-1”, J. nanobiotech., 8 (1), 1 (2010).
[15] Lu, L., Sun, R., Chen, R., Hui, C. K., Ho, C. M., Luk, J. M., Lau, G. and Che, C. M., “Silver nanoparticles inhibit hepatitis B virus replication”, Antiv. Ther., 13 (2), 253 (2008).
[16] Gurunathan, S., Han, J. W., Dayem, A. A., Eppakayala, V., Park, J. H., Cho, S. G., Lee, K. J. and Kim, J. H., “Green synthesis of anisotropic silver nanoparticles and its potential cytotoxicity in human breast cancer cells (MCF-7)”, J. Ind. Eng. Chem., 19 (5), 1600 (2013).
[17] Rutberg, F., Dubina, M., Kolikov, V. Moiseenko, F., Ignat’eva, E., Volkov, N., Snetov, V. and Stogov. A. Y., “Effect of silver oxide nanoparticles on tumor growth in vivo”, Doklady Biochem. Biophys. Springer, (2008).
[18] Asharani, P., Hande, M. P. and Valiyaveettil, S., “Anti-proliferative activity of silver nanoparticles”, BMC Cell Biology., 10 (1), 65 (2009).
[19] Sriram, N., Kalayarasan, S. and Sudhandiran, G., “Enhancement of antioxidant defense system by epigallocatechin-3-gallate during bleomycin induced experimental pulmonary fibrosis”, Biol. Pharm. Bull., 31 (7), 1306 (2008).
[20] Langer, K., Balthasar, S., Vogel, V., Dinauer, N., Von Briesen, H. and Schubert, D., “Optimization of the preparation process for human serum albumin (HSA) nanoparticles”, Int. J. Pharm., 257 (1), 169 (2003).
[21] Fisher, G. A. and Sikic, B. I., “Clinical studies with modulators of multidrug resistance”, Hematology/Oncology Clinics of North America, 9 (2), 363 (1995).
[22] Ohsumi, K., Ohishi, K., Morinaga, Y., Nakagawa, R., Suga, Y., Sekiyama, T., Akiyama, Y., Tsuji, T. and Tsuruo, T., “N-alkylated 1, 4-dihydropyridines: new agents to overcome multidrug resistance”, Chem. Pharm. Bul., 43 (5), 818 (1995).
[23] Marklund, S. and Marklund, G., “Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase”, J. Biochem., 47 (3), 469 (1974).
[24] Sastry, M., Mayya, K. and Bandyopadhyay, K., “pH dependent changes in the optical properties of carboxylic acid derivatized silver colloidal particles”, Colloids. Surf. A: Phys. Eng. Aspects, 127 (1), 221 (1997).
[25] Ahmad, A., Senapati, S., Khan, M. I., Kumar, R., Ramani, R., Srinivas, V. and Sastry, M., “Intracellular synthesis of gold nanoparticles by a novel alkalotolerant actinomycete, Rhodococcus species”, Nanotech, 14 (7), 824 (2003).
[26] Zhao, X., Liu, R., Chi, Z., Teng, Y. and Qin, P., “New insights into the behavior of bovine serum albumin adsorbed onto carbon nanotubes: comprehensive spectroscopic studies”, J. Phys. Chem. B, 114 (16), 5625 (2010).